Fractyl Health, Inc. Diluted Shares Outstanding (Weighted Average)
Fractyl Health, Inc. (GUTS) reported Diluted Shares Outstanding (Weighted Average) of 158.65 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-10
- Fractyl Health, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 158.65M shares, a 223.49% increase year-over-year.
- Fractyl Health, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 158.49M shares, a 224.34% increase year-over-year.
- Fractyl Health, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 140.55M shares, a 189.86% increase year-over-year.
- Fractyl Health, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 64.65M shares, a 34.77% increase year-over-year.
- Fractyl Health, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 75.82M shares, a 74.13% increase from fiscal 2024.
- Fractyl Health, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 43.54M shares, a 1992.01% increase from fiscal 2023.
- Fractyl Health, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 2.08M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 158.65M shares 10-Q · filed 2026-08-10 | 158.57M shares 10-Q · filed 2026-08-10 | 152.56M shares derived: average of 3 quarters · filed 2026-08-10 | 130.59M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 158.49M shares 10-Q · filed 2026-05-12 | 149.52M shares derived: average of 2 quarters · filed 2026-05-12 | 121.23M shares derived: average of 3 quarters · filed 2026-05-12 | 103.18M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | 140.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 102.60M shares derived: average of 2 quarters · filed 2026-03-24 | 84.75M shares derived: average of 3 quarters · filed 2026-08-10 | 75.82M shares 10-K · filed 2026-03-24 |
| 2025-09-30 | 64.65M shares 10-Q · filed 2025-11-12 | 56.85M shares derived: average of 2 quarters · filed 2026-08-10 | 54.24M shares 10-Q · filed 2025-11-12 | 52.76M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | 49.04M shares 10-Q · filed 2026-08-10 | 48.95M shares 10-Q · filed 2026-08-10 | 48.80M shares derived: average of 3 quarters · filed 2026-08-10 | 48.59M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | 48.87M shares 10-Q · filed 2026-05-12 | 48.68M shares derived: average of 2 quarters · filed 2026-05-12 | 48.44M shares derived: average of 3 quarters · filed 2026-05-12 | 48.31M shares derived: average of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | 48.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 48.23M shares derived: average of 2 quarters · filed 2026-03-24 | 48.12M shares derived: average of 3 quarters · filed 2026-03-24 | 43.54M shares 10-K · filed 2026-03-24 |
| 2024-09-30 | 47.97M shares 10-Q · filed 2025-11-12 | 47.94M shares derived: average of 2 quarters · filed 2025-11-12 | 41.89M shares 10-Q · filed 2025-11-12 | 31.93M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 47.90M shares 10-Q · filed 2025-08-12 | 38.82M shares 10-Q · filed 2025-08-12 | 26.58M shares derived: average of 3 quarters · filed 2025-08-12 | 20.46M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 29.74M shares 10-Q · filed 2025-05-13 | 15.92M shares derived: average of 2 quarters · filed 2025-05-13 | 11.31M shares derived: average of 3 quarters · filed 2025-05-13 | 9.00M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 2.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 2.10M shares derived: average of 2 quarters · filed 2025-03-03 | 2.09M shares derived: average of 3 quarters · filed 2025-03-03 | 2.08M shares 10-K · filed 2025-03-03 |
| 2023-09-30 | 2.09M shares 10-Q · filed 2024-11-12 | 2.08M shares derived: average of 2 quarters · filed 2024-11-12 | 2.07M shares 10-Q · filed 2024-11-12 | |
| 2023-06-30 | 2.08M shares 10-Q · filed 2024-08-14 | 2.07M shares 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | 2.06M shares 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |